David W Eyre Selected Research

Bacterial Infections (Bacterial Infection)

1/2023

Interpretable machine learning-based decision support for prediction of antibiotic resistance for complicated urinary tract infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David W Eyre Research Topics

Disease

32	Infections 04/2024 - 05/2014
15	COVID-19 02/2024 - 01/2020
5	Reinfection 02/2024 - 05/2014
4	Clostridium Infections 10/2020 - 02/2012
4	Gonorrhea 01/2020 - 01/2019
3	Cross Infection (Nosocomial Infection) 11/2021 - 04/2017
1	Human Influenza (Influenza) 04/2024
1	Pneumonia (Pneumonitis) 04/2024
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Neoplasms (Cancer) 11/2023
1	Breakthrough Infections 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Pharyngitis (Sore Throat) 08/2022
1	Myalgia 08/2022
1	Ageusia (Hypogeusia) 08/2022
1	Dyspnea (Shortness of Breath) 08/2022
1	Headache (Headaches) 08/2022
1	Fatigue 08/2022
1	Fever (Fevers) 08/2022
1	Cough 08/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Disease Progression 01/2022
1	Anosmia 02/2021
1	Intraabdominal Infections 10/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Hodgkin Disease (Hodgkin's Disease) 11/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 04/2024 - 01/2019
10	Immunoglobulin G (IgG)IBA 11/2023 - 01/2020
8	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 02/2012
6	AntibodiesIBA 11/2023 - 01/2020
6	BNT162 VaccineIBA 01/2022 - 01/2021
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 02/2024 - 08/2022
3	N-(2-cyanoethylene)urea (BA 1)IBA 02/2024 - 08/2022
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2018
3	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2020 - 04/2017
2	SolutionsIBA 02/2024 - 01/2019
2	Vancomycin FDA LinkGeneric 11/2023 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
2	FluoroquinolonesIBA 12/2019 - 04/2017
1	Antiviral Agents (Antivirals)IBA 04/2024
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 04/2024
1	Amoxicillin (Wymox)FDA LinkGeneric 04/2024
1	carbapenemaseIBA 11/2023
1	Linezolid (Zyvox)FDA Link 11/2023
1	Third Generation CephalosporinsIBA 11/2023
1	Nucleocapsid ProteinsIBA 11/2023
1	AntigensIBA 01/2023
1	Infliximab (Remicade)FDA Link 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	vedolizumabIBA 01/2022
1	Palivizumab FDA Link 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	EpitopesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	eravacyclineIBA 10/2020
1	Viral RNAIBA 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Clindamycin (Cleocin)FDA LinkGeneric 12/2019
1	zoliflodacinIBA 01/2019
1	Fluconazole (Zonal)FDA LinkGeneric 10/2018
1	idelalisibIBA 01/2018
1	Brentuximab VedotinIBA 11/2017
1	pixantrone (BBR 2778)IBA 01/2016
1	NucleotidesIBA 05/2014
1	FidaxomicinIBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 06/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2017
1	Self-Testing 01/2023
1	Treatment Delay 01/2022
1	Drug Therapy (Chemotherapy) 11/2017
1	Stem Cell Transplantation 01/2016